Jupiter Neurosciences Inc...
(JUNS)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -4.78M | -4.96M | -4.20M | -1.65M | -3.05M |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 1.20M | 817.25K | 1.30M | 501.03K | 944.58K |
| Other Working Capital | 2.18M | 1.61M | 810.31K | 921.94K | 930.83K |
| Other Non-Cash Items | 755.91K | 1.34M | 381.43K | -127.74K | 865.63K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 2.35M | 1.55M | 781.29K | 1.03M | 1.09M |
| Operating Cash Flow | -480.95K | -1.25M | -1.74M | -254.78K | -142.95K |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | 390.00K | 982.33K | 527.65K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 1.33M | 461.50K | 107.79K |
| Financial Cash Flow | 445.00K | 982.33K | 1.86M | 461.50K | 107.79K |
| Net Cash Flow | -35.95K | -266.17K | 122.60K | 206.72K | -35.16K |
| Free Cash Flow | -480.95K | -1.25M | -1.74M | -254.78K | -142.95K |